You are viewing: Japan Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Japan Long Read Sequencing Market was valued at $18.2 Million in 2024 and projected to reach to $78.5 Million by 2029, representing a compound annual growth rate of 34.0%. Japan's long read sequencing market is poised for exceptional growth through 2029, driven by increasing adoption in clinical diagnostics, cancer research, and rare disease identification.

Japan Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 34.0%, significantly outpacing global trends and reflecting Japan's commitment to advanced genomic technologies.
  • Japan's healthcare sector is increasingly adopting long read sequencing for precision medicine, rare disease diagnosis, and cancer genomics applications. The growth trajectory in Japan is driven by substantial investments in research infrastructure, collaborations between academic institutions and biotechnology firms, and government support for genomic medicine initiatives.
  • Japan's aging population and prevalence of genetic disorders have created strong demand for diagnostic sequencing capabilities.
  • By 2029, Japan is expected to establish itself as a key regional hub for long read sequencing adoption across Asia Pacific. Japan's market expansion is supported by technological advancements, declining sequencing costs, and integration of long read platforms into clinical workflows.
  • Japan's regulatory environment and quality standards continue to attract international sequencing technology providers, further accelerating market penetration and innovation within Japan..

Key Market Statistics

  • CAGR (2024-2029) 34.0% CAGR
  • Market Size, 2024 ~USD 18.2 Million
  • Forecast, 2029 ~USD 78.5 Million
  • Country Japan

Japan Long Read Sequencing Market Overview

Market Valuation Growth :

Japan's long read sequencing market is valued at $18.2 million in 2024 and is projected to reach $78.5 million by 2029, representing a 331% increase over the five-year forecast period.

Superior Growth Rate :

Japan's market CAGR of 34% significantly exceeds the global average of 32.8%, positioning the country as a high-growth hub for long read sequencing adoption in Asia-Pacific.

Precision Medicine Integration :

Japanese healthcare institutions are increasingly integrating long read sequencing into precision medicine programs, driven by aging population demographics and demand for advanced diagnostic capabilities.

Technological Infrastructure :

Japan's robust healthcare infrastructure, combined with government support for genomic research initiatives, creates a favorable environment for long read sequencing technology deployment and innovation.

Japan Long Read Sequencing Market Dynamics

  • The country's advanced healthcare system and significant investment in genomic technologies position it as a regional leader.
  • Government initiatives supporting precision medicine and genomic research, coupled with rising healthcare expenditure, will accelerate market expansion.
  • Japanese pharmaceutical and diagnostic companies are actively integrating long read sequencing into their portfolios, further strengthening market momentum and creating opportunities for technology providers and service providers..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Japan's long read sequencing market is valued at $18.2 million in 2024 and will grow to $78.5 million by 2029, representing a 34.0% CAGR.
    • Japan's aging population and high prevalence of genetic disorders are primary drivers of long read sequencing adoption in clinical diagnostics.
    • Government support and academic-industry collaborations in Japan are accelerating technology integration and market expansion.
    • Japan is positioned to become a leading regional market for long read sequencing within Asia Pacific by 2029.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Japan Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    JAPAN: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE9.212.41620.827.636.849.769.534.2
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS2.73.64.76.28.211.11521.235.1
    OTHER END USER1.72.12.63.23.94.867.624.1
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES4.25.77.39.512.516.722.431.334
    TOTAL17.723.930.539.652.269.493.1129.633.5

    Target Audience

    • Diagnostic Companies : Japanese and international diagnostic firms need market intelligence to develop localized long read sequencing offerings, understand reimbursement pathways, and identify clinical adoption opportunities in Japan's healthcare system.
    • Sequencing Technology Providers : Equipment manufacturers and software developers require Japan-specific market data to assess market potential, competitive positioning, and customer acquisition strategies in this high-growth regional market.
    • Healthcare Institutions : Japanese hospitals, research centers, and academic medical centers need market insights to justify investments in long read sequencing infrastructure and align genomic capabilities with precision medicine initiatives.
    • Pharmaceutical & Biotech Companies : Drug developers and biotech firms operating in Japan require market analysis to inform clinical trial design, companion diagnostic development, and precision medicine strategy specific to Japanese populations.
    • Investment & Strategy Teams : Venture capital, private equity, and corporate strategy teams need Japan market data to evaluate investment opportunities, assess growth potential, and identify acquisition targets in the sequencing ecosystem.

    Reasons to Buy this Report

    • Market-Specific Growth Data : Access detailed Japan-specific market sizing, CAGR projections, and five-year forecasts to inform strategic planning and investment decisions in the region's high-growth sequencing sector.
    • Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, key players, and market positioning relative to global trends, enabling targeted go-to-market strategies for the Japanese healthcare market.
    • Regulatory & Reimbursement Insights : Gain comprehensive understanding of Japan-specific regulatory frameworks, reimbursement policies, and healthcare system requirements affecting long read sequencing adoption and commercialization.
    • Clinical Application Trends : Identify priority clinical applications driving adoption in Japan, including cancer genomics, rare disease diagnosis, and precision medicine initiatives specific to Japanese patient populations.
    • Investment & Partnership Opportunities : Discover strategic partnership opportunities, funding landscape, and collaboration potential with Japanese healthcare institutions, research centers, and diagnostic companies in the sequencing space.

    Frequently asked questions

    What is the current market size of long read sequencing in Japan?

    Japan's long read sequencing market was valued at $18.2 million in 2024 and is expected to grow significantly through 2029.

    What is the projected market size for long read sequencing in Japan by 2029?

    Japan's long read sequencing market is forecasted to reach $78.5 million by 2029, representing substantial growth from 2024 levels.

    What is the CAGR for Japan's long read sequencing market?

    Japan's long read sequencing market is growing at a compound annual growth rate of 34.0% between 2024 and 2029.

    What factors are driving growth in Japan's long read sequencing market?

    Key drivers include Japan's aging population, government genomic medicine initiatives, academic-industry partnerships, and increasing adoption in precision medicine and rare disease diagnosis.

    How does Japan's long read sequencing market compare to global trends?

    Japan's 34.0% CAGR exceeds the global average of 32.8%, positioning Japan as a high-growth market within the Asia Pacific region.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status